Please login to the form below

Not currently logged in
Email:
Password:

BMS promotes Paul Biondi to head of business development

He willnow lead the development of its strategic partnerships

Bristol-Myers Squibb BMS Paul BiondiBristol-Myers Squibb has promoted Paul Biondi to senior VP, head of business development, a role that will see him lead the development of strategic partnerships.

Biondi will also be tasked with pursuing scientific innovations across commercial, development, discovery and technology platforms to complement the company's internal R&D pipeline.

Biondi said: “Business development is a key component of Bristol-Myers Squibb's strategy, and has strengthened and diversified our portfolio for long-term growth. 

“We have been successful in executing transactions that make sense strategically, scientifically and economically for our company and partners. I look forward to leading this high-performing team and continuing our pursuit of collaborative partnerships and scientific innovation to help patients.”

He has served at BMS for more than 10 years and was most recently senior vice president, head of R&D Operations.

In his new position Biondi will report to BMS' chief financial officer Charlie Bancroft.

“Paul has established himself as a dynamic and collaborative leader at Bristol-Myers Squibb and made significant contributions over the past 10 years to our success in R&D and business development,” said Bancroft.

“With deep knowledge of our R&D strategy and portfolio, strong business expertise and understanding of the healthcare landscape, Paul is the ideal leader to continue our pursuit of external innovation that helps Bristol-Myers Squibb develop and deliver transformational medicines for patients with serious diseases.”

16th October 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....